Frank Neumann
Corporate Officer/Principal at KITE PHARMA INC
Profile
Frank Neumann is currently the Head-Clinical Development at Kite Pharma, Inc. He was previously the Vice President & Head-Oncology Clinical Research at bluebird bio, Inc. and the Chief Medical Officer at Verastem, Inc. He holds a doctorate degree from the University of Bonn and Heinrich-Heine-Universität Düsseldorf.
Frank Neumann active positions
| Companies | Position | Start |
|---|---|---|
| KITE PHARMA INC | Corporate Officer/Principal | 2020-12-31 |
Former positions of Frank Neumann
| Companies | Position | End |
|---|---|---|
| VERASTEM, INC. | Chief Tech/Sci/R&D Officer | 2021-01-19 |
| BLUEBIRD BIO, INC. | Corporate Officer/Principal | - |
Training of Frank Neumann
| Heinrich-Heine-Universität Düsseldorf | Doctorate Degree |
| University of Bonn | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| VERASTEM, INC. | Health Technology |
| BLUEBIRD BIO, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Stock Market
- Insiders
- Frank Neumann
